Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H23FN4O2 |
Molecular Weight | 382.4321 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)[C@@]([H])(C(=N)O)NC(=O)c1c2ccccc2n(Cc3ccc(cc3)F)n1
InChI
InChIKey=ZSSGCSINPVBLQD-GOSISDBHSA-N
InChI=1S/C21H23FN4O2/c1-21(2,3)18(19(23)27)24-20(28)17-15-6-4-5-7-16(15)26(25-17)12-13-8-10-14(22)11-9-13/h4-11,18H,12H2,1-3H3,(H2,23,27)(H,24,28)/t18-/m1/s1
Molecular Formula | C21H23FN4O2 |
Molecular Weight | 382.4321 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide [ADB-FUBINACA] is a synthetic cannabinoid, a Schedule I drug. ADB-FUBINACA acts as a high potency agonist of cannabinoid CB1 receptor. The compound considered to be a component of illicit smoking mixtures "spice".
Originator
Sources: https://www.google.com/patents/WO2009106982A1 | https://www.ncbi.nlm.nih.gov/pubmed/26134475
Curator's Comment:: # Pfizer
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL218 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26134475 |
0.36 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
UPLC/ESI-MS/MS-based determination of metabolism of several new illicit drugs, ADB-FUBINACA, AB-FUBINACA, AB-PINACA, QUPIC, 5F-QUPIC and α-PVT, by human liver microsome. | 2014 Jun |
|
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. | 2015 Sep 16 |
|
Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order. | 2017 Apr 10 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Jun 25 20:40:15 UTC 2021
by
admin
on
Fri Jun 25 20:40:15 UTC 2021
|
Record UNII |
05235E1S2O
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
7010
Created by
admin on Fri Jun 25 20:40:15 UTC 2021 , Edited by admin on Fri Jun 25 20:40:15 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
58124399
Created by
admin on Fri Jun 25 20:40:15 UTC 2021 , Edited by admin on Fri Jun 25 20:40:15 UTC 2021
|
PRIMARY | |||
|
05235E1S2O
Created by
admin on Fri Jun 25 20:40:15 UTC 2021 , Edited by admin on Fri Jun 25 20:40:15 UTC 2021
|
PRIMARY | |||
|
ADB-FUBINACA
Created by
admin on Fri Jun 25 20:40:15 UTC 2021 , Edited by admin on Fri Jun 25 20:40:15 UTC 2021
|
PRIMARY | |||
|
1445583-51-6
Created by
admin on Fri Jun 25 20:40:15 UTC 2021 , Edited by admin on Fri Jun 25 20:40:15 UTC 2021
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
1185282-00-1
Created by
admin on Fri Jun 25 20:40:15 UTC 2021 , Edited by admin on Fri Jun 25 20:40:15 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
EC50
|
||
|
TARGET -> AGONIST |
EC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |